Sign in / Join Now
ETFs & Funds
Next biotech plays under consideration. Like $
as long shot financially but with a slam dunk technology. So cheap, will likely buy.
Add a reply...
Latest StockTalks »
people get ONCS breaking news and analysis by email alert.
Get email alerts on ONCS »
OncoSec Medical Incorporated
Get latest price
From other sites
OncoSec Granted Orphan Drug Designation From The U.S. FDA For The Treatment Of Unresectable Metastatic Melanoma
at TheStreet (Jun 8, 2017)
OncoSec To Present At LD Micro Invitational
at TheStreet (Jun 2, 2017)
OncoSec To Host Third Quarter Financial Conference Call On June 1, 2017
at TheStreet (May 11, 2017)
OncoSec Announces Clinical Collaboration With Merck To Evaluate Combination Of ImmunoPulse® IL-12 And KEYTRUDA® (pembrolizumab) For Metastatic Melanoma
at TheStreet (May 10, 2017)
OncoSec To Present At Biomarkers & Immuno-Oncology World Congress 2017
at TheStreet (May 2, 2017)